CellSeed's Regenerative medicine technology
CellSeed continue to focus our efforts on commercializing cell sheet regenerative medicine to bring these products to market.
- IR Announcement of the starting of the supply of the cell cultureware to the company, developing the cells for research of the infectious disease
- IR Fiscal 2020 First-Half Earnings Results Presentation
- IR Summary of Consolidated Financial Results for the Six Months Ended June 30, 2020 (J-GAAP)
- IR Summary of Consolidated Financial Results for the Three Months Ended March 31, 2020 (J-GAAP)
- Others Bridge Report the fiscal year 2019